Treatment of severe symptomatic aortic stenosis has undergone significant changes with the advent of transcatheter aortic valve replacement (TAVR). Initially reserved for inoperable patients, these devices have improved; outcomes now rival or outperform surgical treatment. TAVR is recommended for high-risk and certain intermediate-risk patients. As transcatheter aortic valve replacement becomes an option for younger, healthier patients, long-term planning and thoughtful considerations of potential subsequent interventions are paramount. A robust understanding of risks, benefits and expected outcomes with TAVR is critical to provide patients with the best treatment option.
- Aortic stenosis
- Appropriate use
- Transcatheter therapeutics
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine